Suppr超能文献

子痫前期患者循环中的淋巴管生成因子

Circulating lymphangiogenic factors in preeclampsia.

作者信息

Lely A Titia, Salahuddin Saira, Holwerda Kim M, Karumanchi S Ananth, Rana Sarosh

机构信息

Department of Obstetrics and Gynaecology, University Medical Center Groningen, University of Groningen, Hanzeplein 1,Groningen, The Netherlands.

出版信息

Hypertens Pregnancy. 2013;32(1):42-9. doi: 10.3109/10641955.2012.697953. Epub 2012 Sep 7.

Abstract

BACKGROUND

Preeclampsia (PE), a human pregnancy-specific disorder is characterized by an anti-angiogenic state due to high levels of circulating soluble vascular endothelial growth factor 1 (sVEGFR-1). However, the role of lymphangiogenesis in PE has not been investigated. Recently, impaired vascular endothelial growth factor C (VEGF-C) (factor that regulates lymphangiogenesis) signaling has been implicated in the pathogenesis of interstitial edema and salt-sensitive hypertension. Therefore, we hypothesized that circulating VEGF-C and its circulating receptors (sVEGFR-2 and sVEGFR-3) may also be altered in PE and correlate with the severity of the phenotype.

METHODS

We analyzed plasma levels of VEGF-C, sVEGFR-1, sVEGFR-2, and sVEGFR-3 in women with gestational hypertension (GHTN, n = 20), PE (n = 20), and normotensive pregnancies (NP, n = 20) in the third trimester and values were reported as mean ± SD in pg/mL.

RESULTS

As previously reported, sVEGFR-1 levels were significantly higher in subjects with PE (19,938 ± 12,973) than in GHTN (7156 ± 5432), p < 0.01 or NP (7760 ± 6018), p < 0.01. VEGF-C levels were lower in subjects with GHTN (676 ± 323) than in PE (1335 ± 625), p < 0.01, but not statistically different than in NP (971 ± 556), p = 0.11. There was a trend toward lower sVEGFR-2 in PE as compared to GHTN or NP. Interestingly, sVEGFR-3 was significantly lower in PE (54,371 ± 21,107) as compared to NP (83,709 ± 24,983), p < 0.01, but not different as compared to GHTN (54,642 ± 26,947). The ratio of sVEGFR-2 + sVEGFR-3/VEGF-C was dramatically lower during PE (57 ± 38) as compared to GHTN (113 ± 72), p < 0.01 or NP (133 ± 91), p < 0.01.

CONCLUSIONS

PE is characterized by circulating pro-lymphangiogenic state as evidenced by decreased sVEGFR-3, slightly decreased sVEGFR-2, increased VEGF-C, and a dramatically lower ratio of sVEGFR-2 + sVEGFR-3/VEGF-C. Our data suggest that the circulating pro-lymphangiogenic state during PE may be a compensatory response to edema and hypertension. Additional studies are needed to evaluate the clinical relevance of the altered lymphangiogenic signaling pathway during PE.

摘要

背景

子痫前期(PE)是一种人类妊娠特有的疾病,其特征是由于循环中高水平的可溶性血管内皮生长因子1(sVEGFR-1)导致的抗血管生成状态。然而,淋巴管生成在PE中的作用尚未得到研究。最近,血管内皮生长因子C(VEGF-C,一种调节淋巴管生成的因子)信号受损与间质性水肿和盐敏感性高血压的发病机制有关。因此,我们推测循环中的VEGF-C及其循环受体(sVEGFR-2和sVEGFR-3)在PE中也可能发生改变,并与该疾病表型的严重程度相关。

方法

我们分析了妊娠晚期患有妊娠期高血压(GHTN,n = 20)、PE(n = 20)和血压正常的孕妇(NP,n = 20)血浆中VEGF-C、sVEGFR-1、sVEGFR-2和sVEGFR-3的水平,结果以pg/mL为单位表示为平均值±标准差。

结果

如先前报道,PE患者(19,938 ± 12,973)的sVEGFR-1水平显著高于GHTN患者(7156 ± 5432),p < 0.01,或高于NP患者(7760 ± 6018),p < 0.01。GHTN患者(676 ± 323)的VEGF-C水平低于PE患者(1335 ± 625),p < 0.01,但与NP患者(971 ± 556)相比无统计学差异,p = 0.11。与GHTN或NP相比,PE患者的sVEGFR-2有降低趋势。有趣的是,与NP患者(83,709 ± 24,983)相比,PE患者的sVEGFR-3显著降低(54,371 ± 21,107),p < 0.01,但与GHTN患者(54,642 ± 26,947)相比无差异。与GHTN患者(113 ± 72),p < 0.01或NP患者(133 ± 91),p < 0.01相比,PE患者中sVEGFR-2 + sVEGFR-3/VEGF-C的比值显著降低(57 ± 38)。

结论

PE的特征是循环中促淋巴管生成状态,表现为sVEGFR-3降低、sVEGFR-2略有降低、VEGF-C升高以及sVEGFR-2 + sVEGFR-3/VEGF-C的比值显著降低。我们的数据表明,PE期间循环中的促淋巴管生成状态可能是对水肿和高血压的一种代偿反应。需要进一步研究来评估PE期间淋巴管生成信号通路改变的临床相关性。

相似文献

1
Circulating lymphangiogenic factors in preeclampsia.
Hypertens Pregnancy. 2013;32(1):42-9. doi: 10.3109/10641955.2012.697953. Epub 2012 Sep 7.
2
PP016. Circulating lymphangiogenic factors in preeclampsia.
Pregnancy Hypertens. 2012 Jul;2(3):249-50. doi: 10.1016/j.preghy.2012.04.127. Epub 2012 Jun 13.
3
Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma.
J Matern Fetal Neonatal Med. 2010 Feb;23(2):167-78. doi: 10.3109/14767050903067378.
8
VEGF and its soluble receptor VEGFR-2 in hypertensive disorders during pregnancy: the Indian scenario.
J Hum Hypertens. 2012 Mar;26(3):196-204. doi: 10.1038/jhh.2011.17. Epub 2011 Mar 17.
9
Unexplained fetal death: another anti-angiogenic state.
J Matern Fetal Neonatal Med. 2007 Jul;20(7):495-507. doi: 10.1080/14767050701413022.
10
The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes.
Hypertens Pregnancy. 2014 Feb;33(1):81-92. doi: 10.3109/10641955.2013.837175. Epub 2013 Dec 19.

引用本文的文献

1
HIV-associated preeclampsia: evaluation of lymphangiogenesis in placental bed samples.
Histochem Cell Biol. 2025 May 22;163(1):55. doi: 10.1007/s00418-025-02359-4.
4
HIV Associated Preeclampsia: A Multifactorial Appraisal.
Int J Mol Sci. 2021 Aug 25;22(17):9157. doi: 10.3390/ijms22179157.
7
Decreased serum level and increased urinary excretion of vascular endothelial growth factor-C in patients with chronic kidney disease.
Kidney Res Clin Pract. 2013 Jun;32(2):66-71. doi: 10.1016/j.krcp.2013.05.001. Epub 2013 Jun 14.
8
Magnetic resonance-determined sodium removal from tissue stores in hemodialysis patients.
Kidney Int. 2015 Feb;87(2):434-41. doi: 10.1038/ki.2014.269. Epub 2014 Aug 6.
9

本文引用的文献

3
Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Circulation. 2010 Aug 3;122(5):478-87. doi: 10.1161/CIRCULATIONAHA.109.895458. Epub 2010 Jul 19.
6
Soluble endoglin contributes to the pathogenesis of preeclampsia.
Nat Med. 2006 Jun;12(6):642-9. doi: 10.1038/nm1429. Epub 2006 Jun 4.
7
8
Preeclampsia: a renal perspective.
Kidney Int. 2005 Jun;67(6):2101-13. doi: 10.1111/j.1523-1755.2005.00316.x.
9
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
Circ Res. 2004 Oct 29;95(9):884-91. doi: 10.1161/01.RES.0000147365.86159.f5. Epub 2004 Oct 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验